Now live: Pro — the full 13F research suite for serious investorsSee pricing →
ADAMS STREET PARTNERS LLC

Q4 2023 · 13F-HR

ADAMS STREET PARTNERS LLCholdings as filed

Filed 2024-02-14 · accession 0001104659-24-023021

$324.6M
Reported value
14
Positions
2023-12-31
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
70438V106PCTYPaylocity Holding Corporation$93.7M28.9%568,412CommonSOLE
76674Q107RMNIRimini Street, Inc.$77.1M23.7%23,565,433CommonSOLE
19260Q107COINCoinbase Global, Inc.$41.4M12.8%238,149CommonSOLE
74736L109QTWOQ2 Holdings, Inc.$33.8M10.4%777,562CommonSOLE
36118A100Fusion Pharmaceuticals, Inc.$28.3M8.73%2,947,809CommonSOLE
603170101MLYSMineralys Therapeutics, Inc.$19.8M6.10%2,302,329CommonSOLE
90364P105PATHUiPath, Inc.$13.4M4.13%539,111CommonSOLE
91854V107Vacasa, Inc.$7.7M2.37%938,225CommonSOLE
221015100CRVSCorvus Pharmaceuticals, Inc.$5.8M1.78%3,275,616CommonSOLE
48553T106BZKanzhun Limited$1.6M0.49%94,809CommonSOLE
604749101MIRMMirum Pharmaceuticals, Inc.$963,1490.30%32,627CommonSOLE
22207T101BASECouchbase, Inc.$598,0640.18%26,557CommonSOLE
90353T100UBERUber Technologies, Inc.$292,8270.09%4,756CommonSOLE
74767V109QSQuantumscape Corp$224,5750.07%32,313CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.